SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
To date, cancer diseases are one of the leading causes of mortality and morbidity in the world. Recent advances in understanding the molecular genetic mechanisms of oncogenesis and anti-cancer immune responses open new opportunities for the development of novel effective therapeutic strategies again...
Guardado en:
Autores principales: | T. S. Nepomnyashchikh, E. V. Gavrilova, R. A. Maksyutov |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c797440fe6244527ad58c8df1f2d8ed5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
por: Masmudur M. Rahman, et al.
Publicado: (2021) -
Oncolytic Virotherapy
Publicado: (2016) -
SHORT OVERVIEW OF CLINICAL TRIALS WITH CURRENT IMMUNOTHERAPEUTIC TOOLS FOR CANCER TREATMENT
por: T. S. Nepomnyashchikh, et al.
Publicado: (2017) -
The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
por: Xin Xie, et al.
Publicado: (2022) -
Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
por: Gang Shi, et al.
Publicado: (2021)